Torsade de pointes associated with intravenous haloperidol [1];Haloperidol por vía intravenosa y torsade de pointes

Medicina Intensiva

Volumn 28, Issue 2, 2004, Pages 89-

  Herrero Hernandez R ^a   Cidoncha Gallego, M ^a   Herrero De Lucas, E ^a   Jimenez Lendinez M ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HALOPERIDOL; PANTOPRAZOLE; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM; PYRIDOXINE; THIAMINE;

ADULT; ALCOHOLIC PANCREATITIS; CASE REPORT; DISEASE ASSOCIATION; DRUG INDUCED DISEASE; DRUG USE; ELECTROCARDIOGRAM; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; INTENSIVE CARE UNIT; LETTER; MALE; QT INTERVAL; RESTLESSNESS; TORSADE DES POINTES;

EID: 2342569052     PISSN: 02105691     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0210-5691(04)70023-6     Document Type: Letter

References (5)

1. O'Brien JM, Rockwood RP, Suh KI. Haloperidol-Induced Torsade de Pointes. Ann Pharmacother 1999;33:1046-50.
2. Tesar GE, Murray GB, Cassem NH. Use of high-dose intravenous haloperidol in the treatment of agitated cardiac patients. J Clin Psychopharmacol 1985;5:344-7.
3. Hatta K, Takahashi T, Nakamura H, Yamashiro H, Asukai N, Matsuzaki I, et al. The association between intravenous haloperidol and prolonged QT interval. J Clin Psychopharmacol 2001;21:257-61.
4. Sharma ND, Rosman HS, Padhi ID, Tisdale JE. Torsades de Pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81:238-40.
5. Wilt JL, Minnema AM, Johnson RF, Rosenblum AM. Torsade de Pointes associated with the use of intravenous haloperidol. Ann Intern Med 1993;119:391-4.